Adventures in Patent Drafting: Making Your Crystal Ball Work for You!

Moderator: Scott Chapple, Novartis Pharmaceuticals Corporation, Fort Worth, TX

Topics

Administrative Law for the Patent Prosecutor: Effectively Using an Underutilized Tool
David Boundy, Proper Orange, LLC, Cambridge MA

Revisiting §102 after Helsinn: An Update on Caselaw and Real-World Issues of Prior Art Including Public Use and Sale
Laura Arneson, Mueting Raasch Group, PA, Minneapolis, MN

Is It Time to Embrace the Problem-Solution Approach When Drafting Patent Applications with an Aim of Obtaining Protection in Multiple Jurisdictions? 
This presentation will focus on the problem-solution approach to describing inventions and how its use can enhance drafting of multi-jurisdictional patent applications.
Yelena Morozova, Finnegan Henderson Farabow Garrett & Dunner, LLP, London, United Kingdom

Should You Change How You Draft Applications in View of USPTO’s New Emphasis on §112 and Recent Case Law?
This presentation will focus on functional claiming, written description, and other Section 112 topics.
Theresa Stadheim, Schwegman Lundberg & Woessner, PA, Minneapolis, MN

Speakers

• Arneson, Laura

  Mueting Raasch Group | Attorney

  Laura N. Arneson is a patent attorney experienced in the areas of biotechnology and the biomedical sciences. She will soon start an in-house position after seven years at Mueting Raasch Group in Minneapolis, MN.
• Boundy, David

  Potomac Law Group | Partner

  David Boundy is a Partner in our Intellectual Property and Administrative Law practices, advising clients in strategic development of intellectual property as an integrated asset of the business, and synergizing intellectual property with legal, R&D, finance, and marketing. Mr. Boundy is listed as one of the 300 leading intellectual property strategists in the world. He has represented and counseled inventors, investors, startups, and established companies in intellectual property matters. The scope of representation includes patent prosecution, licensing, counseling to avoid litigation, opinions, financing and public offering transactions, due diligence, acquisitions, and spinoffs. His special expertise is in structuring startups’ IP portfolios to maximize financing.
• Chapple, Scott

  Novartis Pharmaceuticals Corporation | Head of Pharmaceutical Patents

• Morozova, Yelena

  Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | Partner

  Yelena Morozova is a partner in the London office of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP / Finnegan Europe LLP. With a professional career spanning across three countries and twenty years of legal experience across two continents, Yelena’s unique background enables her to understand cultural nuances and helps her to advise a broad range of clients across the world. Qualified as a patent attorney in the United States and Europe, Yelena focuses her practice on global patent procurement and portfolio development in all fields of engineering, and most particularly in information technology and software, AI, self-driving vehicles, electric battery systems, and eVTOL aircrafts.
• Stadheim, Theresa

  Schwegman Lundberg & Woessner, P.A. | Principal

  Theresa Stadheim is a registered patent attorney at Schwegman Lundberg & Woessner.